CLINICAL TRIALS PROFILE FOR ODEVIXIBAT
✉ Email this page to a colleague
All Clinical Trials for ODEVIXIBAT
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT04336722 ↗ | Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD) | Recruiting | Albireo | Phase 3 | 2020-07-10 | Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in children with biliary atresia who have undergone a Kasai hepatoportoenterostomy. |
| NCT04674761 ↗ | Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome | Recruiting | Albireo | Phase 3 | 2021-03-19 | Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in Patients with Alagille Syndrome. |
| NCT05035030 ↗ | Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome | Enrolling by invitation | Albireo | Phase 3 | 2021-09-03 | An Open Label Study to Evaluate the Long-term Safety and Efficacy of Odevixibat (A4250) in Patients with Alagille Syndrome (ASSERT-EXT) |
| NCT05426733 ↗ | An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia | Enrolling by invitation | Albireo | Phase 3 | 2022-07-01 | An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ODEVIXIBAT
Condition Name
Clinical Trial Locations for ODEVIXIBAT
Trials by Country
Clinical Trial Progress for ODEVIXIBAT
Clinical Trial Phase
Clinical Trial Sponsors for ODEVIXIBAT
Sponsor Name
